Learn More
BACKGROUND The field of new biological agents is increasing exponentially over the past years, thus making prevention and management of associated infectious complications a challenge for(More)
UNLABELLED The generation of vaccines against HIV/AIDS able to induce long-lasting protective immunity remains a major goal in the HIV field. The modest efficacy (31.2%) against HIV infection(More)
UNLABELLED NYVAC, a highly attenuated, replication-restricted poxvirus, is a safe and immunogenic vaccine vector. Deletion of immune evasion genes from the poxvirus genome is an attractive strategy(More)